MiR-200b-5p inhibits tumor progression in salivary adenoid cystic carcinoma via targeting BTBD1
- PMID: 37290676
- DOI: 10.1016/j.cellsig.2023.110748
MiR-200b-5p inhibits tumor progression in salivary adenoid cystic carcinoma via targeting BTBD1
Abstract
Salivary adenoid cystic carcinoma (SACC) is a rare malignant tumor of the salivary gland. Studies have suggested that miRNA may play a crucial role in the invasion and metastasis of SACC. This study aimed to investigate the role of miR-200b-5p in SACC progression. Reverse transcription-quantitative PCR and western blot assay were used to detect the expression levels of miR-200b-5p and BTBD1. The biological functions of miR-200b-5p were evaluated via wound-healing assays, transwell assays, and xenograft nude mice model. The interaction between miR-200b-5p and BTBD1 was assessed using luciferase assay. Results showed that miR-200b-5p was downregulated in the SACC tissues while BTBD1 was upregulated. miR-200b-5p overexpression suppressed SACC cell proliferation, migration, invasion, and epithelial-mesenchymal transition (EMT). Bioinformatics prediction and luciferase reporter assay revealed that miR-200b-5p could directly bind to BTBD1. Besides, miR-200b-5p overexpression could rescue the tumor-promoting effect of BTBD1. miR-200b-5p inhibited tumor progression by modulating EMT-related proteins, targeting BTBD1 and inhibiting PI3K/AKT signaling pathway. Overall, our findings indicate that miR-200b-5p can suppress SACC proliferation, migration, invasion, and EMT by regulating BTBD1 and PI3K/AKT axis, providing a promising therapeutic target for SACC treatment.
Keywords: BTBD1; PI3K/AKT; Salivary adenoid cystic carcinoma (SACC); Tumor progression; miR-200b-5p.
Copyright © 2023 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest None.
Similar articles
-
miR-582-5p inhibits invasion and migration of salivary adenoid cystic carcinoma cells by targeting FOXC1.Jpn J Clin Oncol. 2017 Aug 1;47(8):690-698. doi: 10.1093/jjco/hyx073. Jpn J Clin Oncol. 2017. PMID: 28591777
-
EGF/EGFR Promotes Salivary Adenoid Cystic Carcinoma Cell Malignant Neural Invasion via Activation of PI3K/AKT and MEK/ERK Signaling.Curr Cancer Drug Targets. 2022;22(7):603-616. doi: 10.2174/1568009622666220411112312. Curr Cancer Drug Targets. 2022. PMID: 35410600
-
Upregulation of lncRNA ADAMTS9-AS2 Promotes Salivary Adenoid Cystic Carcinoma Metastasis via PI3K/Akt and MEK/Erk Signaling.Mol Ther. 2018 Dec 5;26(12):2766-2778. doi: 10.1016/j.ymthe.2018.08.018. Epub 2018 Aug 24. Mol Ther. 2018. PMID: 30217729 Free PMC article.
-
MicroRNA-181a suppresses salivary adenoid cystic carcinoma metastasis by targeting MAPK-Snai2 pathway.Biochim Biophys Acta. 2013 Nov;1830(11):5258-66. doi: 10.1016/j.bbagen.2013.07.028. Epub 2013 Aug 2. Biochim Biophys Acta. 2013. PMID: 23911747
-
Induction of perineural invasion in salivary adenoid cystic carcinoma by circular RNA RNF111.Clin Transl Oncol. 2023 Nov;25(11):3152-3164. doi: 10.1007/s12094-023-03182-w. Epub 2023 May 24. Clin Transl Oncol. 2023. PMID: 37222950
Cited by
-
Dynamic Role of miRNAs in Salivary Gland Carcinomas: From Biomarkers to Therapeutic Targets.Head Neck Pathol. 2024 Feb 23;18(1):12. doi: 10.1007/s12105-023-01603-4. Head Neck Pathol. 2024. PMID: 38393615 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical